Viewing Study NCT06343597



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06343597
Status: RECRUITING
Last Update Posted: 2024-04-02
First Post: 2022-04-27

Brief Title: Volume Outcome Relationships and Effects
Sponsor: Methodist Health System
Organization: Methodist Health System

Study Overview

Official Title: Volume Outcome Relationships and Effects of Adjuvant and Neoadjuvant Therapy in Mortality in Esophageal Cancer
Status: RECRUITING
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities
Detailed Description: This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities

The relationship between volume and outcomes has been proven in pancreatic cancer Similar to pancreatic cancer esophageal cancer historically has a bad prognosis Esophageal cancer is typically asymptomatic resulting in an advanced stage at the time of diagnosis Additionally it also has a significantly high morbidity and mortality Therefore it is crucial to determine volume-outcome relationships in esophageal cancer This study aims to elucidate what these findings may entail by evaluating the impact that the volume-outcome relationship has on treatment assessment in esophageal cancer patients

The purpose of the study is to evaluate the outcomes of esophageal cancer resection in patients in high volume more than 5 esophagectomy performed per year and low volume less than 5 esophagectomy performed per year hospital facilities Furthermore this paper will assess the outcomes of neoadjuvant and adjuvant therapy in esophageal cancer

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None